Development and validation of a selective marker-based quantification of polysorbate 20 in biopharmaceutical formulations using UPLC QDa detection
Introduction
Non-ionic surfactants like polysorbates are often used in biopharmaceutical formulations to stabilize the protein against several environmental stress conditions. Polysorbate 20 and polysorbate 80 are widely used in parenteral formulation development, because of their biocompatibility and their low toxicity [1], although the stabilization mechanism(s) for biologics is unclear [2], [3].
According to the Ph. Eur. polysorbates are a heterogeneous mixture of partial esters of fatty acids with sorbitan and isosorbide which are further ethoxylated with polymerized ethylene oxide [4], [5]. The chemical synthesis starts with the dehydration of sorbitol to form a mixture of sorbitan and isosorbide followed by the addition of fatty acids and their subsequent esterification. Finally, the mixture is ethoxylated with OE (oxyethylene) units to form sorbitan and isosorbide alkyl esters [6], [7]. For polysorbate 20 at least 9 different fatty acids are listed in the Ph. Eur. [8].
Recently, the degradation of polysorbate has emerged as a major challenge in the biopharmaceutical community. Two major degradation mechanisms are known: hydrolysis and oxidation [9]. While oxidation is likely in biopharmaceutical formulations and might be reduced by addition of radical scavengers and/or changing polysorbate quality [10], [11], hydrolysis should not be expected under pharmaceutical relevant solution conditions [12]. However, the presence of traces of host cell proteins like esterases as residues from the drug substance manufacturing process can lead to hydrolytic degradation of polysorbates [13], [14], [15]. Currently, the enzyme(s) are not really identified; a few, specific enzymes were reported in the literature, among these are discussed PLBL2, LPL, phospholipase A2, LPLA2, carboxylester hydrolases, that have been shown to degrade polysorbate [13], [14], [15], [16], [17], [18], [19], [20]. Dependent on which degradation mechanism prevails, the degradation products are various. Non-esterified ethoxylated sorbitans and isosorbides and corresponding free fatty acids (FFA) mostly occur through hydrolysis. Zhang et al. (2017) have observed similar degradations due to oxidation of all-laurate polysorbate 20, namely the formation of free lauric acid and polyoxyethylene (POE) [21].
Depending on their water solubility and the amount of intact polysorbate present, the typically poor water soluble FFA can finally phase-separate leading to the appearance of sub-visible and visible particles [22], [23], [24], [25]. The appearance of FFA might also impair protein stability. Other degradation products particularly formed during oxidation are aldehydes and ketones which might also influence the stability of the formulation, such as the formation of aldehyde adducts [26]. For this reason, monitoring of polysorbate and its degradation products is of importance throughout the development and, stabilization of biologics. Consequently, the need of a reliable quantification method for polysorbate is enormous and very challenging due to the complexity of the mixture. A number of methods were developed in the last decades. Most of them are capable to screen several polysorbate components and assess the polysorbate composition qualitatively or determine a defined component of polysorbate as reference marker of quantification [27]. One of the first and well-known method is the quantification of polysorbate by fluorescence micelle assay (FMA). The assay uses the hydrophobe fluorescent probe such as N-phenyl-1-naphthylamine (NPN) that incorporates in hydrophobe regions and/or interacts with hydrophobe interfaces [19]. As amphiphiles, polysorbate forms micelles above a specific concentration. As a consequence of the physico-chemical properties of NPN, the dye incorporates in the hydrophobic core of the micelles. With increasing micelle concentration, the fluorescent signal increases and allows a direct determination of the polysorbate concentration, more precisely the presence of micelles [28]. The advantages of this method are its simplicity and assay rapidness. The major drawback is that the method only detects polysorbate compounds that form micelles and it does not differentiate between different polysorbate components [29], [30]. Furthermore, as polysorbate degrades, FFA are released and also might form micelles.
The progress in the development of analytical instruments has resulted in a number of polysorbate methods being based on reversed-phase high performance liquid chromatography (RP-HPLC or UHPLC) coupled with a variety of different detectors. This enabled a more robust detection of several different polysorbate components. Detection methods that are based on evaporation techniques like evaporation light scattering (ELSD) and charged aerosol (CAD) are widely used [30], [31]. To separate the analyte from the protein, mostly mixed mode columns are applied, at which the polysorbate components are bound. The chromatographic separation of the polysorbate components is carried out on a second column [32]. Depending on the protein format used in the formulation, it is sometimes challenging to separate the protein completely and to avoid a remaining concentration of protein in addition to polysorbate on the column (protein carry-over). This results in distorted peaks which go along with an inaccurate determination of polysorbate. Nevertheless, these methods are helpful to support the qualitative determination, the polysorbate finger print, and monitor differences in polysorbate components by overlaying several chromatograms of different samples, for instance. For a more precise determination of polysorbate composition, mass spectrometry (MS) is widely used [4], [5], [21], [33] and even hydrodynamic profiling (HAP) by NMR spectroscopy was recently used for polysorbate analysis [34]. Only a few methods are available to quantify specific components of polysorbate by MS in biopharmaceutical formulations. However, these methods use complex techniques like coupling of two-dimensional liquid chromatography with MS [32] or monitor just selected polysorbate compounds as the esterified and ethoxylated species [13], [15].
The reason of the presented new method development was to set up a stability-indicating method for the main components of polysorbate 20 and their hydrolytic degradation products. Therefore, the aim of the present study was to develop an assay for the quantification of a large number of polysorbate 20 compounds, obtained by chemical hydrolysis, using just one method without the need of derivatization and complex detection techniques. Furthermore, it allows to select specific marker peaks that assesses the potential degradation pathway. Based on this consideration, the QDa detector, a single quadrupole mass spectrometer, appears to be very suitable for this purpose. This detection technique was already used for the quantification of free fatty acids during polysorbate hydrolysis [35], [36], but was not used for the monitoring and selective marker-based quantification of different polysorbate components so far. The QDa mass detector combines the analytical confidence and sensitivity of a mass detection. In addition, the risk of unexpected co-elutions of components is minimized. Its reduced complexity of the tuning options and its generic detection parameters leads to a straightforward use of the detector [35].
This paper describes the method development and validation to reliably quantify marker-based components of polysorbate 20.
Section snippets
Materials
Polysorbate 20 high purity (polysorbate 20) was purchased from CRODA GmbH (Nettetal, Germany). Two different testing solutions (protein solutions without polysorbate 20) were used. The two different protein-samples were composed of a monoclonal antibody (mAb) immunoglobulin G (IgG) formulated in phosphate buffer and trehalose at pH 6.2 without the presence of polysorbate. The protein concentration of protein-sample A was 10 mg/mL and for protein-sample B 150 mg/mL. Glacial acetic acid, methanol
Method development
The development of the presented UPLC QDa method for the quantification of polysorbate 20 was based on the established RP-HPLC method coupled with a charged aerosol detector [20]. A C8 column was used as stationary phase while the mobile phase was a gradient of water to acetonitrile. With this chromatographic separation and the further separated investigation of individual peaks by mass spectrometry we have already revealed the presence of various different fatty acid esters along with
Conclusions
In recent years, many analytical methods of polysorbate in biopharmaceutical formulations were described in the literature. Most of them were based on chromatographic separations of several polysorbate components resulting in qualitative evaluations. In case the components have been characterized more closely, techniques like mass spectrometry (MS) and nuclear magnetic resonance spectroscopy (NMR) were used.
The presented method combines a chromatographic separation with a simple and robust mass
CRediT authorship contribution statement
Dirk-Heinrich Evers: Conceptualization, Methodology, Investigation, Writing - original draft. Torsten Schultz-Fademrecht: Conceptualization, Investigation, Writing - review & editing. Patrick Garidel: Resources, Writing - review & editing. Julia Buske: Resources, Writing - original draft, Supervision.
Declaration of Competing Interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Acknowledgements
We acknowledge Mridula Dwivedi, Jean Schuchardt, Katharina Holstein, Stefan Carle, Ingo Presser, Kerstin Walke (Boehringer Ingelheim Pharma GmbH & Co KG) as well as Sascha Gorissen, Julia Puschmann, Janek Giebel, Michael Herbig (RaDes GmbH) for their support and discussions.
References (42)
Polysorbates 20 and 80 used in the formulation of protein biotherapeutics: Structure and degradation pathways
J. Pharm. Sci.
(2008)- et al.
Degradation of polysorbates 20 and 80: Studies on thermal autoxidation and hydrolysis
J. Pharm. Sci.
(2011) - et al.
Factors influencing polysorbate's sensitivity against enzymatic hydrolysis and oxidative degradation
J. Pharm. Sci.
(2019) - et al.
Edetate disodium as a polysorbate degradation and monoclonal antibody oxidation stabilizer
J. Pharm. Sci.
(2019) - et al.
Residual host cell protein promotes polysorbate 20 degradation in a sulfatase drug product leading to free fatty acid particles
J. Pharm. Sci.
(2016) - et al.
Polysorbates 20 and 80 Degradation by Group XV Lysosomal Phospholipase A<inf>2</inf> Isomer X1 in Monoclonal Antibody Formulations
J. Pharm. Sci.
(2016) Ester hydrolysis of polysorbate 80 in mAb drug product: Evidence in support of the hypothesized risk after the observation of visible particulate in mAb formulations
J. Pharm. Sci.
(2014)- et al.
Polysorbate degradation in biotherapeutic formulations: Identification and discussion of current root causes
Int. J. Pharm.
(2018) - et al.
Free fatty acid particles in protein formulations, Part 1: Microspectroscopic identification
J. Pharm. Sci.
(2015) - et al.
Free fatty acid particles in protein formulations, Part 2: Contribution of polysorbate raw material
J. Pharm. Sci.
(2015)
Reduced subvisible particle formation in lyophilized intravenous immunoglobulin formulations containing polysorbate 20
J. Pharm. Sci.
Trends on analytical characterization of polysorbates and their degradation products in biopharmaceutical formulations
J. Pharm. Sci.
Determination of the critical micelle concentration of surfactants using the fluorescent probe N-phenyl-1-naphthylamine
Anal. Biochem.
Impact of mono- and poly-ester fractions on polysorbate quantitation using mixed-mode HPLC-CAD/ELSD and the fluorescence micelle assay
J. Pharm. Biomed. Anal.
Quantitation of polysorbate 20 in protein solutions using mixed-mode chromatography and evaporative light scattering detection
J. Chromatogr. A
Monitoring polysorbate hydrolysis in biopharmaceuticals using a QC-ready free fatty acid quantification method
J. Chromatogr., B: Anal. Technol. Biomed. Life Sci.
Development of a design of experiments optimized method for quantification of polysorbate 80 based on oleic acid using UHPLC-MS
J. Chromatogr. A
Oxidative degradation of polysorbate surfactants studied by liquid chromatography-mass spectrometry
J. Pharm. Sci.
Mixed-mode and reversed-phase liquid chromatography-tandem mass spectrometry methodologies to study composition and base hydrolysis of polysorbate 20 and 80
J. Chromatogr. A
Key interactions of surfactants in therapeutic protein formulations: A review
Eur. J. Pharm. Biopharm.
Notorious but not understood: How liquid-air interfacial stress triggers protein aggregation
Int. J. Pharm.
Cited by (19)
All-in-one stability indicating polysorbate 20 degradation root-cause analytics via UPLC-QDa
2024, Journal of Chromatography B: Analytical Technologies in the Biomedical and Life SciencesOxidation of polysorbates – An underestimated degradation pathway?
2023, International Journal of Pharmaceutics: XHow enzymatic hydrolysis of polysorbate 20 influences colloidal protein stability
2023, European Journal of Pharmaceutical SciencesLeveraging mass detection to simultaneously quantify surfactant content and degradation mode for highly concentrated biopharmaceuticals
2023, Journal of Pharmaceutical and Biomedical AnalysisExistence of a superior polysorbate fraction in respect to protein stabilization and particle formation?
2023, International Journal of PharmaceuticsAnalytical methods for surfactant characterization in biologic drug products
2023, Surfactants in Biopharmaceutical Development